"Boost" in vaccine efficacy seen with hepatitis B exposure
Article Abstract:
Hepatitis B virus (HBV) exposure in a substantial number of Alaskan native vaccinees boosts the vaccine's protective effect. This was found in a 10-year study of the native Alaskan population, for whom the virus is endemic, by the Centers for Disease Control and Prevention. According to Lisa R. Bulkow and colleagues, repeated exposure to HBV enhances the duration of the protection accorded by good HBV vaccine coverage and results in increases in anti-hepatitis B levels.
Publication Name: World Disease Weekly Plus
Subject: Health
ISSN:
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Combination RSAG1/IL-12 vaccine protects against toxoplasmosis in mice
Article Abstract:
Researcher Valerie Letscher-Bru and his colleagues from the Institute de Parasitologie et de Pathologie Tropicale, France and Roche Diagnostics, Switzerland, studied the immune response brought about by Toxoplasma gondii rSAG1 protein in mice. The protein was administered with Interleukin-12 as an adjuvant to the animals which were then challenged four weeks after the last immunization.
Publication Name: World Disease Weekly Plus
Subject: Health
ISSN:
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Published data show FluMist vaccine effective against influenza. HEV prevalence data may not be accurate
- Abstracts: Changing clinical practice. Changing urine testing protocols through audit
- Abstracts: Health and Human Rights. An introduction to the philosophical presuppositions of the animal liberation/rights movement
- Abstracts: Topical microbicides: current status and research considerations for adolescent girls. The value of workplace versus income in determining HIV status and other STDs among a sample of Spanish sex workers